These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22713259)

  • 1. Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa.
    Firnhaber C; Westreich D; Schulze D; Williams S; Siminya M; Michelow P; Levin S; Faesen M; Smith JS
    J Int AIDS Soc; 2012 Jun; 15(2):17382. PubMed ID: 22713259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous intraepithelial lesions in HIV-infected women: prevalence, incidence, progression and regression.
    Kreitchmann R; Bajotto H; da Silva DA; Fuchs SC
    Arch Gynecol Obstet; 2013 Nov; 288(5):1107-13. PubMed ID: 23644923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3.
    Sirera G; Videla S; López-Blázquez R; Llatjos M; Tarrats A; Castellà E; Grane N; Tural C; Rey-Joly C; Clotet B
    J Antimicrob Chemother; 2008 Jan; 61(1):191-4. PubMed ID: 17977910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort.
    Omar T; Schwartz S; Hanrahan C; Modisenyane T; Tshabangu N; Golub JE; McIntyre JA; Gray GE; Mohapi L; Martinson NA
    AIDS; 2011 Jan; 25(1):87-94. PubMed ID: 21076276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
    Ahdieh-Grant L; Li R; Levine AM; Massad LS; Strickler HD; Minkoff H; Moxley M; Palefsky J; Sacks H; Burk RD; Gange SJ
    J Natl Cancer Inst; 2004 Jul; 96(14):1070-6. PubMed ID: 15265968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of cervical cytologic changes among HIV-infected women with normal cytology in the HAART era.
    Sirera G; Videla S; López-Blázquez R; Llatjos M; Tarrats A; Castellà E; Grane N; Alcalde C; Tural C; Rey-Joly C; Clotet B
    AIDS Res Hum Retroviruses; 2007 Aug; 23(8):965-71. PubMed ID: 17725412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
    Heard I; Potard V; Costagliola D
    Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART.
    Adler DH; Kakinami L; Modisenyane T; Tshabangu N; Mohapi L; De Bruyn G; Martinson NA; Omar T
    AIDS; 2012 Aug; 26(13):1645-52. PubMed ID: 22555167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women.
    Blitz S; Baxter J; Raboud J; Walmsley S; Rachlis A; Smaill F; Ferenczy A; Coutlée F; Hankins C; Money D;
    J Infect Dis; 2013 Aug; 208(3):454-62. PubMed ID: 23624362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of highly active antiretroviral therapy (HAART) and menopause on risk of progression of cervical dysplasia in human immune-deficiency virus- (HIV-) infected women.
    Kim SC; Messing S; Shah K; Luque AE
    Infect Dis Obstet Gynecol; 2013; 2013():784718. PubMed ID: 24453469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical squamous intraepithelial lesions among HIV-positive women on antiretroviral therapy in Kenya.
    McKenzie KP; Rogers RK; Njoroge JW; John-Stewart G; Richardson BA; Mugo NR; De Vuyst H; Pamnani RN; Rana FS; Warui D; Chung MH
    Curr HIV Res; 2011 Apr; 9(3):180-5. PubMed ID: 21585334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Risk Factors of Cervical Dysplasia among Human Immunodeficiency Virus Sero-Positive Females on Highly Active Antiretroviral Therapy in Enugu, Southeastern, Nigeria.
    Ogu CO; Achukwu PU; Nkwo PO
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):2987-2994. PubMed ID: 31653145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women.
    Minkoff H; Ahdieh L; Massad LS; Anastos K; Watts DH; Melnick S; Muderspach L; Burk R; Palefsky J
    AIDS; 2001 Nov; 15(16):2157-64. PubMed ID: 11684935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research.
    Menon S; Rossi R; Zdraveska N; Kariisa M; Acharya SD; Vanden Broeck D; Callens S
    BMJ Open; 2017 Aug; 7(8):e015123. PubMed ID: 28780541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results.
    Harris TG; Burk RD; Palefsky JM; Massad LS; Bang JY; Anastos K; Minkoff H; Hall CB; Bacon MC; Levine AM; Watts DH; Silverberg MJ; Xue X; Melnick SL; Strickler HD
    JAMA; 2005 Mar; 293(12):1471-6. PubMed ID: 15784870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study.
    Massad LS; Ahdieh L; Benning L; Minkoff H; Greenblatt RM; Watts H; Miotti P; Anastos K; Moxley M; Muderspach LI; Melnick S
    J Acquir Immune Defic Syndr; 2001 Aug; 27(5):432-42. PubMed ID: 11511819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injectable and oral contraception and the incidence and progression of cervical disease in HIV-infected women in South Africa.
    Westreich D; Jamal N; Smith JS; Schulze D; Williams S; Michelow P; Levin S; Firnhaber C
    Contraception; 2014 Apr; 89(4):286-91. PubMed ID: 24485095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology.
    Paramsothy P; Jamieson DJ; Heilig CM; Schuman PC; Klein RS; Shah KV; Rompalo AM; Cu-Uvin S; Duerr A
    Obstet Gynecol; 2009 Jan; 113(1):26-31. PubMed ID: 19104356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.
    Kelly H; Weiss HA; Benavente Y; de Sanjose S; Mayaud P;
    Lancet HIV; 2018 Jan; 5(1):e45-e58. PubMed ID: 29107561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus-infected women in Johannesburg, South Africa.
    Firnhaber C; Zungu K; Levin S; Michelow P; Montaner LJ; McPhail P; Williamson AL; Allan BR; Van der Horst C; Rinas A; Sanne I
    Acta Cytol; 2009; 53(1):10-7. PubMed ID: 19248549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.